Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Cécile van Steen"'
Publikováno v:
Journal of Ophthalmology, Vol 2022 (2022)
Purpose. To investigate the cost utility of STN1013001, a latanoprost cationic emulsion, versus Latanoprost in patients with open-angle glaucoma or ocular hypertension (OAG/OHT) and concomitant ocular surface disease (OSD) in France. Methods. An earl
Externí odkaz:
https://doaj.org/article/27f3b1d62f564f14812a101be7959ab3
Autor:
Carlo Lazzaro, Cécile van Steen, Giorgio Ghirelli, Matteo Sacchi, Dario Sisto, Maurizio Uva, Luigi Varano, Luigi Angelillo
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research. 23:251-265
STN1013001 is an innovative latanoprost cationic emulsion for open-angle glaucoma/ocular hypertension (OAG/OHT) and ocular surface disease (OSD). A 5-year, 7 health states, 1-year cycle early Markov model-supported cost-utility analysis (CUA) of STN1
Publikováno v:
Clinical Ophthalmology.
Nancy Cross,1 Cécile van Steen,2 Yasmina Zegaoui,1 Andrew Satherley,1 Luigi Angelillo2 1Market Access, Lightning Health, London, UK; 2Market Access, Health Technology Assessment & Health Economics and Outcome Research, Europe, the Middle East and
Publikováno v:
Clinical Ophthalmology.
Nancy Cross,1 Cécile van Steen,2 Yasmina Zegaoui,1 Andrew Satherley,1 Luigi Angelillo2 1Market Access, Lightning Health, London, England, UK; 2Market Access HTA & HEOR, EMEA, Santen GmbH, Munich, Bavaria, GermanyCorrespondence: Yasmina Zegaoui, Ma
Publikováno v:
Health Policy and Technology. :100752